Investing
The startup plans to use AI-backed retinal imaging to find early signs of disease based on tech from Australian company Eyetelligence.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company also laid off workers in the U.K. and Israel as it shifts focus to the U.S. market.
The Boston-based company will use the investment to accelerate growth and expand its platform.
The funds will be used to expand its reach.
The funds will be used to expand the company's team, further develop its platform and increase partnerships.
The company said it plans to use the Series A to expand in the U.K. and Europe, as well as to enter the U.S. market.
The startup said it will use the seed funding to accelerate product development and find customers.
The company will use the funds to expand its reach.
At HIMSS23, Holly Maloney, managing director of General Catalyst, discussed the promise and challenge of using artificial intelligence in healthcare.